Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SIMPLECARE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   9.4% 12.4% 12.7% 19.9% 9.4% 29.4% 19.6% 19.6%   Credit score (0-100)   28 19 17 5 25 1 6 6   Credit rating   BB BB BB B BB C B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   217 125 146 8.9 18.8 -14.7 0.0 0.0   EBITDA   56.0 -86.5 114 -32.4 18.8 -14.7 0.0 0.0   EBIT   56.0 -86.5 114 -32.4 18.8 -14.7 0.0 0.0   Pre-tax profit (PTP)   71.3 -94.3 125.7 -63.9 38.7 14.6 0.0 0.0   Net earnings   57.7 -94.2 118.3 -63.9 38.7 14.6 0.0 0.0   Pre-tax profit without non-rec. items   71.3 -94.3 126 -63.9 38.7 14.6 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   230 135 254 190 229 243 163 163   Interest-bearing liabilities   30.1 32.3 37.3 21.3 40.1 0.0 0.0 0.0   Balance sheet total (assets)   420 267 344 260 291 255 163 163   Net Debt   -164 -157 -279 -220 -244 -252 -163 -163     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   217 125 146 8.9 18.8 -14.7 0.0 0.0   Gross profit growth   -18.2% -42.2% 16.4% -93.9% 110.7% 0.0% 0.0% 0.0%   Employees   1 1 1 1 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   420 267 344 260 291 255 163 163   Balance sheet change%   5.0% -36.6% 29.0% -24.3% 11.7% -12.3% -36.1% 0.0%   Added value   56.0 -86.5 113.5 -32.4 18.8 -14.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 -1.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   25.8% -69.0% 77.7% -362.5% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   17.8% -25.0% 41.7% -8.6% 14.1% 5.4% 0.0% 0.0%   ROI %   26.1% -40.2% 55.6% -10.4% 16.2% 5.7% 0.0% 0.0%   ROE %   28.7% -51.6% 60.8% -28.8% 18.5% 6.2% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   54.6% 50.8% 73.7% 72.9% 78.6% 95.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -292.9% 181.4% -246.2% 678.8% -1,297.6% 1,717.1% 0.0% 0.0%   Gearing %   13.1% 23.8% 14.7% 11.2% 17.6% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.2% 27.0% 5.1% 129.0% 0.2% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.8 1.9 3.7 3.7 4.7 21.3 0.0 0.0   Current Ratio   2.1 1.9 3.7 3.7 4.7 21.3 0.0 0.0   Cash and cash equivalent   194.1 189.2 316.8 241.2 284.5 252.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   160.5 113.8 78.3 53.8 54.0 -4.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   56 -87 114 -32 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   56 -87 114 -32 0 0 0 0   EBIT / employee   56 -87 114 -32 0 0 0 0   Net earnings / employee   58 -94 118 -64 0 0 0 0